IRIS
BOSSI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.589
NA - Nord America 1.997
SA - Sud America 781
EU - Europa 342
AF - Africa 60
OC - Oceania 4
Totale 5.773
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.924
SG - Singapore 1.734
BR - Brasile 710
CN - Cina 538
IT - Italia 87
DE - Germania 79
HK - Hong Kong 67
IN - India 63
GB - Regno Unito 52
CA - Canada 37
BD - Bangladesh 28
TR - Turchia 26
MX - Messico 24
ZA - Sudafrica 21
VE - Venezuela 19
VN - Vietnam 19
UZ - Uzbekistan 17
AR - Argentina 16
UA - Ucraina 16
RU - Federazione Russa 14
EC - Ecuador 13
IQ - Iraq 13
PK - Pakistan 13
FI - Finlandia 12
NL - Olanda 12
ES - Italia 11
KE - Kenya 9
PL - Polonia 9
FR - Francia 8
SE - Svezia 8
AE - Emirati Arabi Uniti 7
AT - Austria 7
IE - Irlanda 7
TW - Taiwan 7
CO - Colombia 6
EG - Egitto 6
JP - Giappone 6
MA - Marocco 6
PH - Filippine 6
TN - Tunisia 6
CL - Cile 5
JO - Giordania 5
NP - Nepal 5
SA - Arabia Saudita 5
AL - Albania 4
ET - Etiopia 4
IR - Iran 4
UY - Uruguay 4
AU - Australia 3
BA - Bosnia-Erzegovina 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
ID - Indonesia 3
JM - Giamaica 3
PE - Perù 3
AM - Armenia 2
BO - Bolivia 2
CY - Cipro 2
GE - Georgia 2
HU - Ungheria 2
IL - Israele 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LT - Lituania 2
PS - Palestinian Territory 2
PY - Paraguay 2
QA - Qatar 2
TT - Trinidad e Tobago 2
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GD - Grenada 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
LB - Libano 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PR - Porto Rico 1
PW - Palau 1
RS - Serbia 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TL - Timor Orientale 1
Totale 5.773
Salva come PNG Salva come JPEG
Città #
The Dalles 867
Singapore 807
Shanghai 514
Seattle 84
Ashburn 63
Hong Kong 57
São Paulo 55
Santa Clara 33
Los Angeles 30
Munich 30
Boardman 28
Milan 26
Naples 26
New York 19
Rio de Janeiro 19
Atlanta 17
Brooklyn 17
Chicago 17
San Francisco 17
Tashkent 17
Belo Horizonte 14
Campinas 14
Brasília 13
Curitiba 13
Buffalo 12
Chandler 12
Secaucus 12
Goiânia 11
Ho Chi Minh City 11
Johannesburg 11
Mexico City 11
Montreal 11
Ribeirão Preto 10
Dallas 9
London 9
Caracas 8
Düsseldorf 8
Helsinki 8
Mumbai 8
Nairobi 8
New Delhi 8
Salvador 8
Warsaw 8
Boston 7
Charlotte 7
Council Bluffs 7
Dhaka 7
Dublin 7
Karachi 7
Phoenix 7
Stockholm 7
Bengaluru 6
Caxias do Sul 6
Chennai 6
Denver 6
Genoa 6
Las Vegas 6
Portsmouth 6
Reston 6
Santo André 6
Sorocaba 6
Vancouver 6
Belém 5
Birigui 5
Carney 5
Fortaleza 5
Guarulhos 5
Istanbul 5
Manchester 5
Philadelphia 5
Porto Alegre 5
Quito 5
São José dos Campos 5
Tokyo 5
Tunis 5
Volta Redonda 5
Wilmington 5
Addis Ababa 4
Agrolândia 4
Amman 4
Amsterdam 4
Blumenau 4
Caruaru 4
Cleveland 4
Colombo 4
Cotia 4
Florianópolis 4
Guayaquil 4
Hanoi 4
Ipatinga 4
Manaus 4
Marília 4
Mauá 4
Montevideo 4
Newark 4
Nuremberg 4
Praia Grande 4
Pretoria 4
San Mateo 4
Santiago 4
Totale 3.269
Salva come PNG Salva come JPEG
Nome #
Role of Radiotherapy in the management of metastases from salivary gland carcinoma. 47
USO DI MIRNA COME BIOMARCATORI PER LA DIAGNOSI E PROGNOSI DEL CARCINOMA ORALE A CELLULE SQUAMOSE 34
Understanding Protective Mechanisms of an Oral Probiotic in Reducing Radiation-Induced Oral Mucositis 33
ESMO Guidelines: Cancer patient management during the COVID-19 pandemic 29
Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancer 28
Guidance on mucositis assessment from the MASCC Mucositis Study Group and ISOO: an international Delphi study 27
Precision medicine in head and neck cancer: from immunotherapy to microbiota, circulating DNA and robotic surgery 27
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact 27
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy 26
Prophylaxis, clinical management, and monitoring of datopotamab deruxtecan-associated oral mucositis/stomatitis 26
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 26
A pilot study of a smartphone-based monitoring intervention on head and neck cancer patients undergoing concurrent chemo-radiotherapy 25
Absence of ALK and MET alterations in head and neck sarcomatoid carcinoma 24
Updated perspectives on the contribution of the microbiome to the pathogenesis of mucositis using the MASCC/ISOO framework 24
A multidisciplinary expert opinion on CINV and RINV, unmet needs and practical real-life approaches 24
Ectopic olfactory neuroblastoma is associated with increased frequency of syndrome of inappropriate antidiuretic hormone secretion and reduced disease control: Case series with systematic review and pooled analysis 23
Computer Vision Foundation Models in Endoscopy: Proof of Concept in Oropharyngeal Cancer 23
A randomized, double-blind, placebo controlled, phase II study to evaluate the efficacy of ginseng in reducing fatigue in patients treated for head and neck cancer 23
A functional gene expression analysis in epithelial sinonasal cancer: Biology and clinical relevance behind three histological subtypes 23
A nationwide survey among emergency physicians and oncologists to improve the management of immune checkpoint inhibitors toxicity 23
Health care-associated infections (HAIs) in head and neck carcinoma (HNC) patients treated with chemotherapy (CT) and/or radiotherapy (RT) 23
A randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy of Aqualief™ mucoadhesive tablets in head and neck cancer patients who developed radiation-induced xerostomia 23
The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports 22
A case of otoliquorrhoea secondary to immunotherapy response in head and neck cutaneous squamous cell carcinoma. When abrupt response may worry the physician 21
A complete remission with androgen-deprivation therapy in a recurrent androgen recptor-expressing adenocarcinoma of the parotid gland [1] 21
Editorial: Understanding and treating rare nasal and paranasal sinus cancers 21
A NATURAL HISTORY OF A SERIES OF RADIOACTIVE IODINE (131I-RAI)-RESISTANT ADVANCED DIFFERENTIATED THYROID CANCER (DTC) 21
Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines 21
What to do and what not to do in the management of cancer pain: A physician survey and expert recommendations 21
Treatment Options for Recurrent Anterior Skull Base Tumors 21
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck 20
Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial 20
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma 20
Does a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer? 20
The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers 20
New trends in supportive care of head and neck cancers 20
Emerging pharmacotherapy trends in preventing and managing oral mucositis induced by chemoradiotherapy and targeted agents 20
Bridging gaps in cancer cachexia Care: Current insights and future perspectives 20
A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients 20
Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements 19
Eliciting Preferences for Clinical Follow-Up in Patients with Head and Neck Cancer Using Best-Worst Scaling 19
Immunonutrition in head and neck cancer patients undergoing chemoradiotherapy: An alternative approach for overcoming potential bias 19
Measuring financial toxicity in head and neck cancer: a systematic review 19
Expression of PDL-1 between primary and recurrent/metastatic head and neck squamous cell carcinoma: A bi-institutional retrospective concordance analysis (CONCORDL-1 study) 19
Treatment decision-making factors and sequencing in recurrent and/or metastatic squamous cell carcinoma of the head and neck 19
Gene signatures and expression of miRNAs associated with efficacy of panitumumab in a head and neck cancer phase II trial 19
Do not throw the baby out with the bathwater: SELECT a personalized, de-escalated lenvatinib schedule allows response in locally advanced DTC while controlling major drug-related bleeding 19
Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines - part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents 19
Fragile Histidine Triad Gene Inactivation in Lung Cancer The European Early Lung Cancer Project 19
The SINTART 1 study. A phase II non-randomised controlled trial of induction chemotherapy, surgery, photon-, proton- and carbon ion-based radiotherapy integration in patients with locally advanced resectable sinonasal tumours 19
Difficulties in conducting pure academic research, obstacles in data collection and quality of informations: The example of the INTERCEPTOR study 19
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines 19
International, Multi-Institutional Evaluation of Practice Patterns and Outcomes for Recurrent and Metastatic Sinonasal Undifferentiated Carcinoma 18
Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies? 18
FURTHER IMPROVEMENT IN OUTCOMES OF NASOPHARYNGEAL CARCINOMA WITH OPTIMIZED RADIOTHERAPY AND INDUCTION PLUS CONCOMITANT CHEMOTHERAPY: AN UPDATE OF THE MILAN EXPERIENCE 18
Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers 18
Treatment de-escalation for HPV+ oropharyngeal cancer: A systematic review and meta-analysis 18
Sinonasal Malignancies of Anterior Skull Base Histology-driven Treatment Strategies 18
Revisiting the concept of neoadjuvant and induction therapy in head and neck cancer with the advent of immunotherapy 18
International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic 18
Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology 18
Biomarkers in head and neck squamous cell carcinoma: unraveling the path to precision immunotherapy 18
A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6 18
The present and the future of benzydamine: expert opinion paper 18
Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review 18
Where do we stand with immunotherapy for nonmelanoma skin cancers in the curative setting? 18
Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer 18
Diving into hot topics of salivary gland carcinoma management—an EORTC young and early career investigator survey 18
Prevention and Management of Osteoradionecrosis in Patients With Head and Neck Cancer Treated With Radiation Therapy: ISOO-MASCC-ASCO Guideline 18
A ct-based radiomic signature can be prognostic for 10-months overall survival in metastatic tumors treated with nivolumab: An exploratory study 18
Prognostic role of baseline 18 F‐FDG pet/CT in squamous cell carcinoma of the paranasal sinuses 17
Radiotherapy for unresectable sinonasal cancers: Dosimetric comparison of intensity modulated radiation therapy with coplanar and non-coplanar volumetric modulated arc therapy 17
Immunotherapy for Nasopharyngeal Carcinoma 17
Temporal course and predictive factors of analgesic opioid requirement for chemoradiation-induced oral mucositis in oropharyngeal cancer 17
Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients 17
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 17
Cohort analysis of safety and efficacy of vismodegib in Italian patients from the Phase II, multicenter STEVIE study 17
Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities? 17
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy 17
Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinoma 17
Dietary intervention for tertiary prevention in head and neck squamous cell carcinoma survivors: clinical and translational results of a randomized phase II trial 17
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin 17
Immunotherapy for Cutaneous Squamous Cell Carcinoma: Results and Perspectives 17
Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN) 17
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer 17
The 2024 International Society of Oral Oncology-Multinational Association of Supportive Care in Cancer-American Society of Clinical Oncology guidelines for the prevention and management of osteoradionecrosis of the jaw 17
Acquired resistance to Hedgehog inhibitor through smoothened mutation in basal cell carcinoma 17
The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity 17
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours 17
Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendations 17
Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands 17
The Evolving Role of Systemic Therapy in the Primary Treatment of Sinonasal Cancer. 17
Feasibility and activity of docetaxel, cisplatinum and 5-fluorouracil (TPF) induction chemotherapy followed by concurrent chemo-radiotherapy (including IMRT) in locally advanced nasopharyngeal cancer (LANPC) 17
Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel 17
Quality Assessment in Supportive Care in Head and Neck Cancer 17
Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients 16
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab 16
Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma 16
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus 16
Is restoring platinum sensitivity the best goal for cetuximab in recurrent/metastatic nasopharyngeal cancer? [15] 16
Totale 2.013
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.497
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.497
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 3 1 1 2 1 0 2
2021/20224 0 0 0 2 0 0 0 1 0 0 1 0
2022/202334 4 0 2 4 5 3 0 1 11 2 1 1
2023/20241.254 2 2 6 0 0 0 1 434 43 53 251 462
2024/20254.244 138 26 56 86 45 395 214 189 825 1.141 533 596
2025/2026688 688 0 0 0 0 0 0 0 0 0 0 0
Totale 6.234